Ralf Kuriyel - Senior VP, R&D at Repligen Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Senior VP, R&D
Stock Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Ralf Kuriyel - trading volume in the past year for Repligen Corp

Holdings reported by Ralf Kuriyel for Repligen Corp

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 23,726 $3.88M $163.34 May 14, 2024 Direct
Stock Option (Right to Buy) 0 Mar 11, 2024 Direct Common Stock

Transactions reported by Ralf Kuriyel for Repligen Corp

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership